Renovaro rises on new CEO, board shake-up as part of restructuring

Lunai Bioworks

16/10/2024 17:15

** Shares of biotech company Renovaro Inc  RENB.O  up 24.4%
at $0.87
    ** David Weinstein appointed as RENB's director and CEO,
succeeding Mark Dybul
    ** Co also names four new directors; board size increased to
five members
    ** Realignment of resources to focus on RENB's AI platform,
Renovaro Cube, which is used for multi-cancer early detection
and patient monitoring
    ** Strategic review to also include pipeline prioritization
and financial initiatives to strengthen co's balance sheet 
    ** Up to last close, stock down ~73.35% YTD

 (Reporting by Rishab Shaju in Bengaluru)
 ((Rishab.shaju@thomsonreuters.com))